Limitations of compensated Jaffe creatinine assays in cirrhotic patients

Clinical Biochemistry

Volumn 45, Issue 4-5, 2012, Pages 320-325

  Kuster, Nils ^a,b   Bargnoux, Anne Sophie ^a,b   Pageaux, Georges Philippe ^a,c   Cristol, Jean Paul ^a,b  

^a MONTPELLIER UNIVERSITY HOSPITAL   (France)

^b University Montpellier 1 et 2   (France)

^c UNIV MONTPELLIER   (France)

Author keywords

Cirrhosis; CKD EPI; Compensated Jaffe creatinine; Cystatin C; Enzymatic creatinine; Estimated glomerular filtration rate

Indexed keywords

CREATININE; CYSTATIN C;

ADOLESCENT; ADULT; AGED; ARTICLE; BIOASSAY; CLINICAL ASSESSMENT TOOL; COMPENSATED JAFFE CREATININE ASSAY; CREATININE BLOOD LEVEL; END STAGE LIVER DISEASE; ENZYMATIC CREATININE ASSAY; FEMALE; GLOMERULAR FILTRATION RATE ESTIMATION; GLOMERULUS FILTRATION RATE; HUMAN; INTERMETHOD COMPARISON; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MODEL FOR END STAGE LIVER DISEASE SCORE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMIDOHYDROLASES; CREATININE; CYSTATIN C; END STAGE LIVER DISEASE; FEMALE; GLOMERULAR FILTRATION RATE; HEMODIALYSIS SOLUTIONS; HUMANS; INDICATOR DILUTION TECHNIQUES; LIVER CIRRHOSIS; MALE; MIDDLE AGED; RENAL INSUFFICIENCY; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84857581485     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2011.11.008     Document Type: Article

References (36)

1. Francoz C., Glotz D., Moreau R., Durand F. The evaluation of renal function and disease in patients with cirrhosis. J Hepatol 2010, 52:605-613.
2. Garcia-Tsao G., Parikh C.R., Viola A. Acute kidney injury in cirrhosis. Hepatology 2008, 48:2064-2077.
3. Pham P.-T.T., Wilkinson A.H. Transplantation: impact of pretransplant renal insufficiency. Liver Transpl 2008, 14:592-595.
4. Wiesner R., Edwards E., Freeman R., Harper A., Kim R., Kamath P., et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 2003, 124:91-96.
5. Francoz C., Prié D., Abdelrazek W., Moreau R., Mandot A., Belghiti J., et al. Inaccuracies of creatinine and creatinine-based equations in candidates for liver transplantation with low creatinine: impact on the model for end-stage liver disease score. Liver Transpl 2010, 16:1169-1177.
6. Myers G.L., Miller W.G., Coresh J., Fleming J., Greenberg N., Greene T., et al. Recommendations for improving serum creatinine measurement: a report from the Laboratory Working Group of the National Kidney Disease Education Program. Clin Chem 2006, 52:5-18.
7. Piéroni L., Delanaye P., Boutten A., Bargnoux A.-S., Rozet E., Delatour V., et al. A multicentric evaluation of IDMS-traceable creatinine enzymatic assays. Clin Chim Acta 2011, 412:2070-2075.
8. Cobbaert C.M., Baadenhuijsen H., Weykamp C.W. Prime time for enzymatic creatinine methods in pediatrics. Clin Chem 2009, 55:549-558.
9. Panteghini M. Enzymatic assays for creatinine: time for action. Clin Chem Lab Med 2008, 46:567-572.
10. Parry D.M. Use of single-value protein compensation of the Jaffe creatinine assay contributes to clinically significant inaccuracy in results. Clin Chem 2008, 54:215-216.
11. Wuyts B., Bernard D., Van den Noortgate N., Van de Walle J., Van Vlem B., De Smet R., et al. Reevaluation of formulas for predicting creatinine clearance in adults and children, using compensated creatinine methods. Clin Chem 2003, 49:1011-1014.
12. Bargnoux A.-S., Simon N., Garrigue V., Dupuy A.-M., Badiou S., Mourad G., et al. Accuracy of GFR predictive equations using ID-MS traceable creatinine: compensated Jaffe and enzymatic. Clin Lab 2011, 57:357-361.
13. Bargnoux A.S., Servel A.C., Piéroni L., Dupuy A.M., Badiou S., Garrigue V., et al. Accuracy of GFR predictive equations in renal transplantation: Validation of a new turbidimetric cystatin C assay on Architect c8000®. Clin Biochem 2012, 45:151-153.
14. Kamath P.S., Kim W.R. The model for end-stage liver disease (MELD). Hepatology 2007, 45:797-805.
15. Levey A.S., Stevens L.A., Schmid C.H., Zhang Y.L., Castro A.F., Feldman H.I., et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009, 150:604-612.
16. Stevens L.A., Coresh J., Schmid C.H., Feldman H.I., Froissart M., Kusek J., et al. Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD. Am J Kidney Dis 2008, 51:395-406.
17. Bland J.M., Altman D.G. Statistical methods for assessing agreement between two methods of clinical measurement. Int J Nurs Stud 2010, 47:931-936.
18. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002, 39:S1-S266.
19. Cholongitas E., Shusang V., Marelli L., Nair D., Thomas M., Patch D., et al. Review article: renal function assessment in cirrhosis - difficulties and alternative measurements. Aliment Pharmacol Ther 2007, 26:969-978.
20. Davenport A. Difficulties in assessing renal function in patients with cirrhosis: potential impact on patient treatment. Intensive Care Med 2011, 37:930-932.
21. Delanghe J.R., Cobbaert C., Harmoinen A., Jansen R., Laitinen P., Panteghini M. Focusing on the clinical impact of standardization of creatinine measurements: a report by the EFCC Working Group on Creatinine Standardization. Clin Chem Lab Med 2011, 49:977-982.
22. Badiou S., Dupuy A.M., Descomps B., Cristolead J.P. Comparison between the enzymatic vitros assay for creatinine determination and three other methods adapted on the Olympus analyzer. J Clin Lab Anal 2003, 17:235-240.
23. Xirouchakis E., Marelli L., Cholongitas E., Manousou P., Calvaruso V., Pleguezuelo M., et al. Comparison of cystatin C and creatinine-based glomerular filtration rate formulas with 51Cr-EDTA clearance in patients with cirrhosis. Clin J Am Soc Nephrol 2011, 6:84-92.
24. Owen L.J., Keevil B.G. Does bilirubin cause interference in Roche creatinine methods?. Clin Chem 2007, 53:370-371.
25. Srisawasdi P., Chaichanajarernkul U., Teerakanjana N., Vanavanan S., Kroll M.H. Exogenous interferences with Jaffe creatinine assays: addition of sodium dodecyl sulfate to reagent eliminates bilirubin and total protein interference with Jaffe methods. J Clin Lab Anal 2010, 24:123-133.
26. Peake M., Whiting M. Measurement of Serum Creatinine - Current Status and Future Goals. Clin Biochem Rev 2006, 27:173-184.
27. O'Leary N., Pembroke A., Duggan P.F. A simplified procedure for eliminating the negative interference of bilirubin in the Jaffé reaction for creatinine. Clin Chem 1992, 38:1749-1751.
28. Lolekha P.H., Jaruthunyaluck S., Srisawasdi P. Deproteinization of serum: another best approach to eliminate all forms of bilirubin interference on serum creatinine by the kinetic Jaffe reaction. J Clin Lab Anal 2001, 15:116-121.
29. Lisman T., van Leeuwen Y., Adelmeijer J., Pereboom I.T.A., Haagsma E.B., van den Berg A.P., et al. Interlaboratory variability in assessment of the model of end-stage liver disease score. Liver Int 2008, 28:1344-1351.
30. Cholongitas E., Marelli L., Kerry A., Senzolo M., Goodier D.W., Nair D., et al. Different methods of creatinine measurement significantly affect MELD scores. Liver Transpl 2007, 13:523-529.
31. Huo T.-I., Lee S.-D., Lin H.-C. Selecting an optimal prognostic system for liver cirrhosis: the model for end-stage liver disease and beyond. Liver Int 2008, 28:606-613.
32. Bernardi M., Gitto S., Biselli M. The MELD score in patients awaiting liver transplant: strengths and weaknesses. J Hepatol 2011, 54:1297-1306.
33. Stevens L.A., Coresh J., Greene T., Levey A.S. Assessing kidney function-measured and estimated glomerular filtration rate. N Engl J Med 2006, 354:2473-2483.
34. Slack A., Yeoman A., Wendon J. Renal dysfunction in chronic liver disease. Crit Care 2010, 14:214.
35. Sherman D.S., Fish D.N., Teitelbaum I. Assessing renal function in cirrhotic patients: problems and pitfalls. Am J Kidney Dis 2003, 41:269-278.
36. Gerhardt T., Pöge U., Stoffel-Wagner B., Palmedo H., Sauerbruch T., Woitas R.P. Creatinine-based glomerular filtration rate estimation in patients with liver disease: the new Chronic Kidney Disease Epidemiology Collaboration equation is not better. Eur J Gastroenterol Hepatol 2011, 23:969-973.